Telomir Pharmaceuticals TELO Cash Flow Statement (2023-2026)

NASDAQ TELO
$1.17 -0.03 (-2.50%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Telomir Pharmaceuticals Quarterly Cash Flow Statement

Periods 13 quarters
Latest Jun 2026

Telomir Pharmaceuticals cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 13 quarters of results from Mar 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Share-based Compensation 2.06M1.38M4.66M-0.74M-0.01M
Cash from Operations -0.74M-0.03M-2.00M-1.09M-1.94M-1.52M-1.00M-0.61M-0.90M-0.66M-0.94M-1.20M
Change in Working Capital
Change in Accured Expenses -0.25M1.39M-1.05M0.02M0.07M-0.08M0.11M0.08M-0.03M-0.30M0.07M0.68M
Financing Activities
Other financing activities 0.02M0.20M
Debt Issuance and Repayment
Long-Term Debt Repayments 0.26M0.32M0.52M-0.09M
Non-Current Debt 0.95M1.00
Short-Term Debt issuances 0.85M0.11M
Short-Term Debt repayments 0.10M
Change in Capital Stock
Shares Issued 28.61M29.76M
Net Equity Issued and Repurchased 1.00M-0.09M0.09M5.83M-5.80M4.50M0.00M
Misc.
Cash from Financing Activities 0.74M0.05M1.99M1.09M5.21M0.13M-0.05M1.04M7.50M1.16M
Change in Cash 388.000.01M-0.01M-0.00M3.27M-1.39M-1.05M0.43M-0.86M0.35M6.57M-0.04M
Free Cash Flow -0.74M-0.03M-2.00M-1.09M-1.94M-1.52M-1.00M-0.61M-0.90M-0.66M-0.94M-1.20M
Net Cash Flow 388.000.01M-0.01M-0.00M3.27M-1.39M-1.05M0.43M-0.90M-0.66M6.56M-0.04M

Telomir Pharmaceuticals Cash Flow Statement API

Pull Telomir Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TELO&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY